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The multilayered epidermis is established through a
stratification program, which is accompanied by a
shift from symmetric toward asymmetric divisions
(ACD), a process under tight control of the transcrip-
tion factor p63. However, the physiological signals
regulating p63 activity in epidermal morphogenesis
remain ill defined. Here, we reveal a role for insulin/
IGF-1 signaling (IIS) in the regulation of p63 activity.
Loss of epidermal IIS leads to a biased loss of ACD,
resulting in impaired stratification. Upon loss of
IIS, FoxO transcription factors are retained in the
nucleus, where they bind and inhibit p63-regulated
transcription. This is reversed by small interfering
RNA-mediated knockdown of FoxOs. Accordingly,
transgenic expression of a constitutive nuclear
FoxO variant in the epidermis abrogates ACD and
inhibits p63-regulated transcription and stratifica-
tion. Collectively, the present study reveals a critical
role for IIS-dependent control of p63 activity in coor-
dination of ACD and stratification during epithelial
morphogenesis.
INTRODUCTION
The mammalian epidermis is a constantly self-renewing protec-
tive barrier against external challenges and dehydration that is
formed and maintained by basal progenitor cells with high prolif-
erative potential. The epidermis arises from a single ectodermal
layer with a stratification program initiated at approximately
embryonic day 12.5 (E12.5). In the single layered developing
epidermis the majority of divisions are symmetric (SCD), produc-
ing two basal cells, but at the onset of stratification the balance
shifts toward asymmetric divisions (ACD), resulting in a basal
and a more differentiated suprabasal cell (Lechler and Fuchs,
2005; Poulson and Lechler, 2010; Williams et al., 2011). The176 Developmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier Inepidermal master regulator p63 controls epidermal stratification
and differentiation, proliferative potential, and division orienta-
tion (Ferone et al., 2013; Koster and Roop, 2007; Lechler and
Fuchs, 2005; Lefkimmiatis et al., 2009; Senoo et al., 2007;
Truong and Khavari, 2007). However, how p63 is regulated to
execute these different functions and if extracellular signals are
required to couple division orientation to epidermal stratification
is largely unclear. We previously identified insulin- and IGF-1
receptor (IR/IGF-1R) signaling in keratinocytes as key regulators
of epidermal morphogenesis and proliferative potential as
epidermal loss of IR, IGF-1R, or both increasingly impaired strat-
ification (Stachelscheid et al., 2008). Insulin/IGF-1 signaling-
mediated inhibition of the FoxO transcription family of Forkhead
proteins is important for the regulation of longevity, metabolism,
and stem cell behavior (Calnan and Brunet, 2008; Tothova and
Gilliland, 2007). FoxOs are phosphorylated by IIS-activated
PKB/Akt, and this results in their export from the nucleus (Kloet
and Burgering, 2011). Here, we show that IIS-mediated regula-
tion of the forkhead transcription factor (FoxO) controls p63-
dependent transcription via a FoxO DNA-binding-independent
interaction with p63 to couple cell cycle progression to spindle
orientation and thereby drive stratification.RESULTS
Epidermal IIS Promotes ACD
To determine how IIS regulates epidermal stratification, we
initially focused on E16.5 mouse embryos carrying a K14-Cre-
mediated (Hafner et al., 2004) epidermal IR and/or IGF-1R
deletion (IRepi/, IGF-1Repi/, or dkoepi), the time point
when the microscopic phenotype first becomes obvious. In con-
trol mice, the transition from E15.5 to E16.5 coincides with an
expansion of the number of suprabasal layers. This expansion
is reduced in the IRepi/, more reduced in the IGF-1Repi/
with dkoepi mice being most affected. In the IGF-1Repi/ and
dkoepi mice this is accompanied by less polarized basal cells
(Stachelscheid et al., 2008; Figure S1A available online). Surpris-
ingly, short term in vivo labeling of BrdU did not reveal a differ-
ence in the E16.5 epidermis whereas at E17.5 incorporationc.
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Figure 1. IIS Controls Epidermal Stratifica-
tion through Promoting Asymmetric Cell
Division
(A) Quantification of short term BrdU-labeled
cells in the basal layer of E16.5 and E17.5 ctr
and dkoepi epidermis (n = 3 embryos/genotype,
mean ± SD).
(B) Reduction of anaphase keratinocytes in
IRepi/, IGF-1Repi/, and dkoepi epidermis at
E16.5 (n = 5 embryos/genotype, mean ± SEM).
Number of cells in anaphase in control was set
at 100%.
(C and D) Biased loss of asymmetric cell divisions
(ACD) in the basal epidermal layer of IGF-1Repi/
and dkoepi mice at E16.5. (C) Radial histogram
quantification of division angles. (n = 3 E16.5
embryos per genotype). (D) Relative comparison
of different division orientation shows a significant
biased loss of ACD in the IGF-1Repi/ (n = 49
divisions) and dkoepi (n = 25) compared to control
(n = 71). Each of the number of symmetric
divisions (SCD), undefined divisions or ACDs of
the control were set to 100%. Significance was
tested separately for each type of division
(SCD, random, and ACDs) using one-way
ANOVA and indicated by *p < 0.05, **p < 0.01,
and ***p < 0.001 (n = 3 E16.5 embryos/genotype,
mean ± SEM).
See also Figure S1.
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IGF/FoxO Control of p63 in Epidermal Developmentwas significantly reduced in dkoepi mice (Figures 1A and S1B),
similar to what was observed using Ki67 (Stachelscheid et al.,
2008). As BrdU is incorporated into the DNA during S-phase, a
late block in the cell cycle provides a possible explanation why
the E16.5 morphological phenotype induced by loss of IGF-
1R/IR is not accompanied by changes in proliferation markers.
In agreement, the number of anaphase spindles was significantly
reduced in E16.5 epidermis of IGF-1Repi/ and dkoepi mice
whereas the IRepi/ mice, which only have a mild defect in
stratification, showed a slight, albeit nonsignificant, reduction
(Figure 1B).
As the expansion of suprabasal layers at E16.5 is at least in
part driven by ACD (Poulson and Lechler, 2010; Williams et al.,
2011), we asked whether epidermal loss of IR/IGF-1R affected
SCD and/or ACD. Ablation of IR, IGF-1R, or both resulted
in biased loss of ACDs most prominent in the epidermis of
IGF-1Repi/ and dkoepi mice (Figures 1C, 1D, S1C, and S1D),
in line with the severity of the stratification phenotype observed
in thesemice. Thus, by preferentially promoting ACD, IIS couples
the regulation of proliferative potential to the expansion of supra-
basal differentiated layers.
Epidermal IIS Drives Mitosis
To determine at which cell cycle stage loss of IIS-induced arrest,
we performed cell cycle analysis. Significantly more cells were in
G2/M in IGF-1R/ keratinocytes compared to control (Fig-
ure 2A). To determine if this was related to an arrest in mitosis,
we counted the number of metaphase and anaphase spindles,
as the mitotic checkpoint is activated between these two mitotic
phases. This revealed an increase in number of metaphase
spindles accompanied by a decrease in number of anaphaseDevespindles either in IGF-1R/ keratinocytes (Figure 2B) or in vivo
in E16.5 dko epidermis (Figure 2C). Thus, loss of epidermal insu-
lin/IGF-1 signaling is associated with a mitotic checkpoint arrest.
To ask if IIS is required duringmitosis, we synchronized human
keratinocytes in S-phase and subsequently serum-starved these
cells during late G2 and arrested cells in mitosis. Release of the
mitotic block combined with addition of either Insulin/IGF-1 or
fetal calf serum (FCS)-induced phosphorylation of Akt (Fig-
ure 2D), indicating that IIS is activated during mitosis, whereas
no activation was observed in the absence of growth factors.
More importantly, addition of Insulin/IGF-1 or the positive-con-
trol FCS was sufficient to release mitotic arrest and drive signif-
icantly more cells into G1 upon release of the block compared to
serum-starved cells (Figure 2E). Together, these results indicate
that IIS activity is directly required during mitosis.
IIS Signaling Regulates p63 Activity
The transcription factor p63 controls proliferative potential,
epidermal stratification, ACD, and cell cycle progression of ker-
atinocytes (Koster and Roop, 2007; Lechler and Fuchs, 2005;
Lefkimmiatis et al., 2009; Senoo et al., 2007; Truong and Khavari,
2007). These processes are also affected by loss of epidermal IIS
(Figure 1) (Stachelscheid et al., 2008). Regulation of p63 might
thus provide a mechanism for how IR/IGF-1R control epidermal
morphogenesis. We therefore asked whether epidermal loss of
IIS altered the transcriptional activity of p63. A significant
increase in luciferase activity was observed in IGF-1R/ kerati-
nocytes compared to control upon transfection of a reporter that
is repressed by p63 (pG13-Luc) (Hermeking et al., 1997; Yang
et al., 1998) (Figure 3A), whereas the activity of the p63-transac-
tivated reporter (BDS-2 (3x)) (Hermeking et al., 1997; King et al.,lopmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier Inc. 177
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Figure 2. Insulin/IGF-1 Is Required for Progression of Mitosis
(A) FACS cell cycle analysis on primary cultured keratinocytes shows an increased number of IGF-1R/ cells in G2/M (n = 5/genotype, mean ± SD). Insert shows
representative propidium iodide cell cycle histograms.
(B and C) Increase in metaphase and reduction in anaphase cells in IGF-1R/ keratinocytes in vitro (B) and in E16.5 dkoepi embryos (C) (n = 3/genotype,
mean ± SD).
(D) Western blot analysis showing increased Akt phosphorylation in serum starved HaCat keratinocytes upon release of mitotic arrest after addition of FCS or
Insulin/IGF-1.
(E) Cell cycle analysis showing that insulin/IGF-1 is sufficient to release mitotic arrest of HaCat keratinocytes, as indicated by an increase of cells in G0/G1.
Serum-starved mitotically arrested keratinocytes were set to 1 (n = 5, mean ± SD).
Significance was tested using Student’s t test and indicated by *p < 0.05, **p < 0.01, and ***p < 0.001.
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IGF/FoxO Control of p63 in Epidermal Development2003) was repressed in IGF-1R/ keratinocytes (Figure 3B).
Thus, the loss of IGF-1R reduced both p63 transactivation
and repressive activities. Importantly, overexpression of p63 in
IGF-1R/ keratinocytes reversed inhibition of the p63-transac-
tivated reporter (Figure 3B).
We next asked if these alterations in p63 transcriptional activ-
ity have functional consequences for p63 target gene expres-
sion. To obtain an unbiased overview, we performed gene
expression analysis on RNA isolated from newborn epidermis
of control and dkoepi mice and compared this to the gene
expression data derived from either mouse keratinocytes in
which p63 was knocked down (Della Gatta et al., 2008) or
p63/ E18.5 whole skin (Koster et al., 2006). This revealed a
statistically highly significant overlap of the dkoepi gene expres-
sion set with both p63-regulated sets (Figure 3C), the percentage
of whichwas in a similar range as the overlap of the two p63 gene
expression sets (Figure S2A). More importantly, a statistically
significant enrichment for gene ontology terms related to
epidermal development was only observed in the overlapping
gene sets of dko with either the p63 KD keratinocytes (4-fold)
or the p63/ E18.5 skin (7-fold) but not in the nonoverlapping
sets (Figures 3C and S2B).178 Developmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier InWe next analyzed the expression of several genes that are
regulated by both IIS and p63, most of which are also direct tar-
gets of p63 (Ferone et al., 2012; Kouwenhoven et al., 2010;West-
fall et al., 2003; Yang et al., 2006). We mostly focused on genes
that have been implicated in epidermal differentiation and/or cell
cycle regulation. Several p63 repressed targets (e.g., 14-3-3s or
Runx2) were upregulated, whereas other targets (e.g., K15
or Tgfbi) are downregulated in the epidermis of both E16.5
IGF-1Repi/ and newborn dkoepi mice (Figures 3D and S2C).
For 14-3-3s, this increase was further confirmed at the protein
level (Figure S2F). Surprisingly, the global gene expression anal-
ysis revealed that several members of the late envelope (Lce)
protein families and small proline rich (Sprr) protein, which are
part of the epidermal differentiation complex (EDC), were highly
upregulated not only in the newborn dkoepi but also in the
different p63 knockout or knockdown gene expression sets
(Della Gatta et al., 2008; Koster et al., 2006). This is consistent
with the complex function of p63 in balancing the promotion of
epidermal stratification while inhibiting a subset of terminal dif-
ferentiation genes or counteracting Notch-induced differentia-
tion (Koster and Roop, 2007; Nguyen et al., 2006). Real-time
PCR analysis confirmed the strong increase in Lce3B, Sprr2i,c.
Developmental Cell
IGF/FoxO Control of p63 in Epidermal Developmentand Sprr2f in the dkoepi (Figure S2D). In contrast, Lce3B was
downregulated in IGF-1Repi/ E16.5 (Figure 3D), albeit that con-
trol expression levels were very low and Sprr2i and Sprr2f mRNA
levels were below detection at this developmental stage. Other
putative p63 targets, such as Fgfr2 (Ferone et al., 2012) were
not affected by loss of IGF-1R or IR/IGF-1R either in vivo (Figures
3D and S2C) or in vitro (Figure S2E). Thus, epidermal IIS signaling
and p63 regulate the expression of an overlapping set of genes.
If a decrease in p63 transcriptional activity is responsible for
the altered expression of a range of p63 target genes in the
epidermis of IGF-1Repi/ or dkoepi mice, then one would predict
less p63 binding to p63 consensus elements in the endogenous
promoters of these altered genes. Based on previously identified
p63-binding sites in promoters in human keratinocytes and cells
(Kouwenhoven et al., 2010; Westfall et al., 2003; Yang et al.,
2006) we identified conserved p63 binding sites in promoters/
enhancers of murine Runx2, Stratifin (Sfn, encoding 14-3-3s),
and Cdkn1a and used the already known site in Fgfr2 (Ferone
et al., 2012) as a control as its expression is not altered upon
IR/IGF-1R loss. We next asked whether p63 binding to these
sites was changed upon loss of IGF-1R. Surprisingly, p63 bind-
ing to the p63 consensus site in these targets was similar in
control and IGF-1R/ keratinocytes in chromatin immunopre-
cipitation quantitative PCR (ChIP-qPCR) (Figure 3E), even
though RNA expression of these targets is altered. In agreement,
loss of IIS signaling did not induce significant changes in p63
expression in either E16.5 IGF-1Repi/ (Figure 3F) or in keratino-
cytes (Figure S2G). Taken together, these findings suggest that
insulin/IGF-1 regulate p63 transcriptional activity independent
of p63 protein expression and promoter binding.
IIS Regulates Epidermal FoxO Activity
TheFoxO family of forkhead transcription factors is one of the key
targets through which IIS exerts its biological effects. IIS nega-
tively controls the transcriptional activity of FoxOs through Akt
phosphorylation-dependent nuclear exclusion of FoxOs (Calnan
andBrunet, 2008). FoxOs play central roles in longevity, stem cell
regulation,metabolism,and tumor suppression (Accili andArden,
2004; Partridge and Bru¨ning, 2008). More importantly, FoxOs
were shown to regulate transcriptional activity of other proteins
independent of binding to their consensus sites in promoters
(Jensen et al., 2011; Nemoto et al., 2004). Thus, FoxO transcrip-
tion factors are potential downstream candidates to mediate IIS
regulation of genes also regulated by p63. However, little is
known on the expression of FoxO members in the epidermis.
Real-time PCR analysis showed that all four members, FoxO1,
FoxO3, FoxO4, and FoxO6, were expressed in E16.5 epidermis
(Figure 4A), the time point when the phenotype induced by loss
of IIS signaling becomes obvious. As IIS does not regulate
nuclear shuttling of FoxO6 (Jacobs et al., 2003), we did not
further analyze this member. Western blot analysis for FoxO1
and FoxO3 also showed protein expression at E16.5 (Figure 4B)
and in newborn (not shown) as well as in primary keratinocytes
(Figure S3A), whereas only a specific band could be detected
for FoxO4 in primary keratinocytes but not E16.5 epidermis,
despite RNA expression (Figure S3A). Thus, FoxO1 and FoxO3
proteins are expressed in E16.5 epidermis.
Loss of IGF-1R did not alter FoxO1 and FoxO3 expression
levels in E16.5 embryos (Figures 4B and S3B). Importantly, usingDevewestern blot analysis, we detected less phospho-FoxO1 in E16.5
IGF-1R/ epidermis compared to control (Figures 4B and 4C),
indicating a loss of IIS-stimulated Akt phosphorylation activity.
This was associated with an increase in nuclear FoxO1 protein
(Figure S3C). Most importantly, FoxO-specific reporter assays
showed increased FoxO transcriptional activity in IGF-1R/
keratinocytes (Figures 4D and S5A). Together, these data sug-
gest that loss of epidermal IIS activates FoxOs.
IIS-Regulated FoxO Inhibits p63 Independent of Its DNA
Binding Properties
To examine whether FoxO can regulate p63, we transfected pri-
mary keratinocytes with either the p63-transactivated reporter or
the p63-repressed reporter in the presence of either GFP,
FoxO1-WT, or of a FoxO1 with mutated Akt phosphorylation
sites (FoxO1-ADA) resulting in a constitutively nuclear FoxO
that thus mimics loss of IR/IGF-1R (Nakae et al., 2000). FoxO1-
WT was used as a control as this is excluded from the nucleus
due to the presence of Insulin/IGF-1 in serum. FoxO1-ADA
inhibited the p63-transactivated reporter (Figure 5A), whereas
the activity of the p63-repressed reporter was upregulated by
FoxO1-ADA (Figure 5B). Thus, nuclear FoxO counteracts p63-
transcriptional activity. Mutation of the FoxO DNA binding
domain (FoxO1-ADA-DDBD) (Kitamura et al., 2007) did not affect
the ability of FoxO1-ADA to repress the p63-transactivated
reporter in primary keratinocytes (Figure S4A). To rule out that
FoxO-ADA can directly bind p63-binding sites, we transfected
CHO cells as these cells do not express p63. FoxO-ADA-medi-
ated repression required cotransfection with p63 (Figure S4B).
To examine whether FoxO directly interacts with p63, we
transfected CHO cells with p63 and FoxO1-ADA and found
that FoxO1-ADA precipitated p63 and vice versa, p63 precipi-
tated FoxO1-ADA (Figure S4C), thus providing evidence that
FoxO1-ADA interacts with p63. More importantly, more endoge-
nous FoxO1 was immunoprecipitated by p63 from IGF-1R/
than from control keratinocytes (Figure 5D). Using K14-Cre
mice carrying a flox-stop-flox-FoxO-GFP cassette under the
control of the Rosa26 promoter (Fukuda et al., 2008), we
expressed FoxO1-GFP in the epidermis either in a control or
IGF-1Repi/ background. GFP immunoprecipitations showed
an increased interaction of p63 with FoxO1-GFP in the absence
of IGF-1R compared to control newborn epidermis (Figure 5E).
Thus, loss of IIS results in nuclear translocation of FoxOs,
where they interact with p63 to counteract p63 transcriptional
activity. This would predict that loss of IGF-1R would promote
an association of FoxOswith p63 sitting on p63 binding sites pre-
sent in endogenous promoters. As already shown, p63 binding
to p63 consensus site containing promoters was not altered by
IIS loss (Figure 3E). FoxO1 ChIP-qPCR experiments in control
and IGF-1R/ keratinocytes showed that upon loss of IGF-1R
FoxO1 was enriched 2- to 3-fold on p63 consensus sites in the
promoters of targets that showed altered expression upon loss
of IGF-1 (e.g., Sfn or Runx2) but not on p63 sites located in tar-
gets with unaffected expression, such as e.g., Fgfr2r (Figure 5F).
In agreement, transfection of FoxO1-ADA-DDBD DNA binding
mutant in control primary keratinocytes increased expression
of these same targets, Runx2 and 14-3-3a (Figure 5C), similar
to in vivo loss of IIS (Figure 3D). These results indicate that
FoxO interacts with p63 on p63-DNA consensus sites to regulatelopmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier Inc. 179
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Figure 3. IIS Regulates p63 Transcriptional Activity
(A) Luciferase reporter assay showing an increased activity of the p63-repressed pG13 reporter in IGF-1R
/ keratinocytes compared to control, which was set
to 1 (n = 4/genotype, mean ± SEM).
(B) Luciferase reporter assay showing a reduced activity of the p63-transactivated BDS-2 (3x) luciferase gene reporter in IGF-1R/ keratinocytes and restoration
of luciferase activity upon transient overexpression of p63. Control activity was set to 1 (n = 4 independent experiments, mean ± SEM).
(C) Gene expression microarray analysis of newborn dkoepi epidermis and comparison with arrays of p63 kd keratinocytes (upper panel) or p63/ E18.5 skin
show overlap in gene sets (Pie charts). The overlap of the arrays is highly significant and was calculated using hypergeometric distribution algorithm (indicated by
p values). Gene ontology (GO) terms for overlapping genes reveal significant enrichment for epidermal and ectodermal development compared to nonover-
lapping GO terms.
(legend continued on next page)
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Figure 4. Epidermal FoxO Transcription Factors Are Regulated by IIS
(A) Quantitative real-time PCR analysis of the FoxO family in E16.5 epidermis and in keratinocytes treated with a combination of siRNAs to FoxO1/3/4 as a
negative control (mean of n = 3, embryos or n = 3 knockdown cell lines ± SEM). Expression of FoxO1 was set to 1.
(B) Western blot analysis showing expression of FoxO1 and FoxO3 in E16.5 epidermis. Loss of IGF-1R does not affect overall expression levels but does reduce
phosphorylation of FoxO1.
(C) Quantification of Phospho-FoxO1 intensities in (B) normalized to total FoxO1 with control set to 1 (mean of n = 3 E16.5 epidermis/genotype ± SD).
(D) Luciferase reporter assay showing an increase in FoxO reporter (6xDBE) activity in IGF-1R/ keratinocytes compared to control, which is set to 1 (n = 4
independent experiments, mean ± SEM).
Statistical significance was tested using Student’s t test. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S3.
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IGF/FoxO Control of p63 in Epidermal Developmentexpression of these p63 targets in a FoxO-DNA-binding-inde-
pendent manner. Most importantly, siRNAmediated knockdown
of FoxO1, -3, and -4 but not a scrambled siRNA reversed the
expression of e.g., 14-3-3s and Runx2 in IGF-1R/ primary
keratinocytes (Figure 5G), whereas these siRNAs showed no
effect in control (Figure S4D), indicating that the increased
expression of these targets upon loss of IGF-1R is a direct
consequence of increased FoxO activity. Together, these find-
ings identify a DNA binding-independent function for FoxOs in
the regulation of p63 activity.
Strongly Impaired Stratification in Mice Expressing
Epidermal FoxO1-ADA
If FoxO functionally counteracts p63 in vivo in a DNA binding-
independent manner, then expression of the constitutive nuclear
FoxO1-ADA, but not a FoxO1-DNA binding-domain-only mutant
(FoxO-DN) (Nakae et al., 2000) in the epidermis, should result in a
skin phenotype that is similar to that caused by loss of p63. In
addition, FoxO-DN should not be able to rescue the impaired
stratification in IGF-1Repi/. We thus crossed mice that carry
a flox-stop-flox cassette followed by either a FoxO1-ADA-
IRES-GFP or FoxO1-DN-IRES-GFP cassette in the Rosa26
locus (Belgardt et al., 2008; Sto¨hr et al., 2013) to the Keratin14-
Cre transgene (Hafner et al., 2004) and in case of the FoxO-DN
also to IGF-1RFl/Fl mice, to induce epidermal expression of the
ADA mutants (FoxO1-DNepi or FoxO1-ADAepi).
FoxO1-DN expression reversed FoxO reporter activity
induced by the loss of IGF-1R in primary keratinocytes isolated(D) Quantitative real-time PCR analysis showing relative gene expression of p63 re
E16.5 embryos/genotype, mean ± SEM). K15, 14-3-3s, and lce3B were only we
(E) Chromatin immunoprecipitation (ChIP)-qPCR assays in primary keratinocytes
target promoters is not affected by loss of IGF-1R (mean of three technical replicat
(F) Immunofluorescence analysis for p63 (red) and keratin14 (green) in the epiderm
IGF-1/IR.
Statistical significance was tested using Student’s t test. *p < 0.05, **p < 0.01, a
See also Figure S2.
Devefrom these mice (Figure S5A), showing that the FoxO DNA
binding mutant was indeed a dominant negative toward
FoxO DNA-binding-dependent transcriptional activity. Expres-
sion of FoxO1-DN did not affect epidermal morphogenesis
(Figure 6A), as predicted based on our observations that the
FoxO1-ADA DNA binding mutant was still able to alter p63 re-
porter activity and gene expression. More importantly, FoxO1-
DN was unable to rescue stratification in IGF-1Repi/ mice
(Figure 6A).
FoxO1-ADA was expressed in the epidermis already at E13.5
(Figures S5B and S5C) and resulted in fragile, translucent
skin and perinatal death (Figure 6B). Histochemical analysis of
newborn mice revealed a striking hypoplastic epidermis (Fig-
ure 6C), which strongly resembled that of p63 knockout mice
(Mills et al., 1999; Yang et al., 1999). This phenotype became first
apparent at E14.5 (Figure S5D) accompanied by a failure to prop-
erly induce the suprabasal differentiation markers keratin10 and
loricrin (Figure 6D), indicating that FoxO1-ADA interferes with
proper initiation of stratification.
Biased Loss of ACD and Altered p63 Target Gene
Expression
TUNEL staining revealed no increase in apoptosis in the devel-
oping epidermis of K14-Cre-FoxO1-ADA mice (Figure S6A),
similar to what was observed in dko epidermis (Stachelscheid
et al., 2008) and thus likely is not causative of the phenotype.
In contrast, E16.5 FoxO1-ADA mice showed a strong reduction
in the number of anaphase divisions in the epidermis (Figure 7A),gulated genes in control (ctr, set as 1) and IGF-1Repi/ E16.5 epidermis (n = 3
akly expressed at E16.5.
showing that the binding of p63 to p63-binding regions in different endogenous
es ± SD). Shown is a representative example of three independent experiments.
is of E16.5 embryos showing that p63 localization is not affected by the loss of
nd ***p < 0.001.
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Figure 5. Insulin/IGF-1-Regulated FoxO Interacts with p63 at p63 Binding Sites
(A and B) Luciferase reporter assays showing that transfection of the constitutive nuclear FoxO1-ADA mutant in primary mouse keratinocytes (A) repressed the
activity of the p63-transactivated reporter BDS-2 (3x) and (B) increased the activity of the p63-repressed reporter pG13 p63 reporter. Luciferase activity was
compared to primary mouse keratinocytes transfected with WT-FoxO1 in (A) and (B) and set to 1 for WT-FoxO1 (mean of n = 4 independent experiments ± SEM).
(C) Real-time PCR analysis showing that a DNA binding deficient mutant of FoxO1 (FoxO1-ADA-DDBD) enhances expression of the p63-repressed targets 14-3-
3s and Runx2. Primary keratinocytes were transiently transfected with either WT-FoxO1 or FoxO1-ADA-DDBD (mean of n = 2 independent experiments ± SD).
(D) Coimmunoprecipitation of endogenous FoxO1 with p63 from primary IGF-1R/ but not control keratinocytes.
(E) Coimmunoprecipitation of p63with FoxO1-GFP from the epidermis of newborn control and IGF-1Repi/mice that also express a FoxO1-GFP in the epidermis
using GFP antibodies.
(F) Chromatin immunoprecipitation (ChIP)-qPCR analysis in primary mouse control and IGF-1R/ keratinocytes using FoxO1 antibodies showing an increased
interaction of FoxO1 with p63-binding regions in promoters of p63 targets. Results were normalized to a negative binding region and are shown as enrichment
over control keratinocyte IP, which was set to 1 (mean of n = 3 independent experiments ± SD; n = 2 for Fgfr2r).
(G) Real-time PCR analysis on primary mouse IGF-1R/ keratinocytes transiently transfected with either scramble or combined knockdown of FoxO1/3/4 using
smart pool siRNAs to each of these FoxOs. FoxO1/3/4 knockdown, but not scrambled, siRNAs reduced expression of different p63 targets that are upregulated
upon loss of IGF-1R/ (mean of n = 4 independent experiments ± SEM).
Values in (A)–(C) and (G) are means ± SEM. Values in (F) are means ± SD. Statistical significance was tested by Student’s t test and indicated as *p < 0.05,
**p < 0.01, and ***p < 0.001.
See also Figure S4.
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Figure 6. Epidermal Expression of Consti-
tutive Nuclear FoxO1 Strongly Impairs
Epidermal Differentiation
(A) H&E staining showing that epidermal expres-
sion of dominant negative FoxO1 (FoxO1-DN) did
not affect epidermal morphogenesis and did not
rescue the impaired stratification of IGF-1Repi/
mice. Scale bar represents 25 mm.
(B and C) Expression of FoxO1-ADA in the
epidermis interferes with stratification. Macro-
scopic appearance of control and FoxO-1ADAepi
newborn mice (B) and H&E stainings of paraffin
sections of newborn mice (C). Scale bar repre-
sents 25 mm.
(D) Immunofluorescence analysis for the
epidermal differentiation markers K10 (green, left)
and loricrin (green) in E13.5, E14.5, and E17.5
control and FoxO1-ADAepi embryos revealed a
strong reduction in differentiation in the FoxO1-
ADAepi mice. Nuclei are counterstained by DAPI.
Scale bar represents 50 mm.
See also Figure S5.
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IGF/FoxO Control of p63 in Epidermal Developmentfurther confirming that FoxO is downstream of IIS in the regula-
tion of epidermal morphogenesis. This was even more pro-
nounced than in dko epidermis (Figure 1B), thus reflecting the
more severe phenotype. This was due to a biased loss of
ACDs (Figures 7B and 7C), as was also observed in IRepi/,
IGF-1Repi/, dkoepi (Figures 1C, 1D, and S1D), and p63
knockout mice (Lechler and Fuchs, 2005).
Most importantly, expression analysis revealed that FoxO1-
ADA expression regulated a similar subset of P63 target genes
in E16.5 epidermis (Figure 7D), most of which were also altered
in E16.5 IGF-1Repi/ epidermis (Figure 3D), whereas targets
not altered by loss of IIS (e.g., FGFR2) were again not changed.
As expected, basal p63 localization was not obviously affec-
ted by epidermal FoxO1-ADA expression (Figure S6B). Thus,
insulin/IGF-1-controlled FoxOs are crucial regulators of p63,
ACD, and epidermal morphogenesis.
DISCUSSION
Our data demonstrate a role for IIS signaling in FoxO-dependent
control of p63, a key determinant of epidermal cell fate, to regu-
late ACD and progression of mitosis during epidermal morpho-
genesis. This allows IGF-1, and to a much lesser extent insulin,
to couple the maintenance of progenitors with high proliferative
potential to suprabasal differentiation. We identify p63 as an
interacting partner of FoxOs and show that FoxO is a negative
regulator of p63 transcriptional activity on a subset of targetsDevelopmental Cell 26, 176–important for epidermal stratification.
Surprisingly, this is independent of FoxO
binding to DNA. This is based on the
following observations: a constitutive
nuclear FoxO, FoxO1-ADA, inhibits tran-
scription of a luciferase reporter that
only contains p63 sites and only in the
presence of p63. More importantly, a
point mutation that prevents DNA bind-
ing, as shown by FoxO reporter assaysFoxO1-ADA-DDBD, still inhibits p63-dependent reporters.
Last, epidermal expression of a mutant FoxO1 that consists
only of its DNA binding domain did not obviously affect
epidermal morphogenesis and, more importantly, was not able
to rescue the phenotype caused by inactivation of IGF-1 (results
not shown). This same FoxO-1 mutant was shown to rescue loss
of IIS in the hypothalamus (Belgardt et al., 2008). In agreement
with our findings, FoxOs can also regulate transcriptional activity
of Myc and p53 independent of binding to the consensus FoxO
recognition element (Jensen et al., 2011; Nemoto et al., 2004).
The p63 transcription factor is crucial for the formation of strat-
ifying epithelia such as epidermis and mutations in human p63
result in ectodermal dysplasia disorders (Koster and Roop,
2007; Vanbokhoven et al., 2011). Except for BMP signaling in
zebrafish (Bakkers et al., 2002), the dermal signals that regulate
p63 have so far remained largely elusive. Here, we identify p63 as
a target of IIS, which is necessary during epidermal morphogen-
esis to inhibit FoxO activity, likely through nuclear export and
thereby prevent FoxO to negatively regulate p63 function. We
find that loss of IIS resulted in a decrease in Akt-dependent
FoxO1 phosphorylation accompanied by an increase in nuclear
FoxO1 protein and, more importantly, increased FoxO transcrip-
tional activity as judged by reporter assays. We were unable to
detect nuclear FoxO by immunohistochemistry. As the FoxO1-
ADA is readily detected in the nucleus (Figure S5C) and
expressed 5-fold more as endogenous FoxO (Figure S5B),
endogenous FoxOs are likely expressed at levels too low to be187, July 29, 2013 ª2013 Elsevier Inc. 183
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Figure 7. Constitutive Nuclear FoxO1 Results in Biased Loss of ACD and Altered p63 Target Gene Expression
(A) Reduction of number of basal keratinocytes in anaphase in E16.5 FoxO1-ADA mice compared to control (n = 3 embryos each genotype, mean of
divisions ± SD).
(B and C) Biased loss of ACD in FoxO1-ADA E16.5 epidermis. (B) Radial histograms quantification of division angles (n = 3 E16.5 embryos/genotype). (C) Relative
comparison of different division orientations shows a significant biased loss of ACD in FoxO1-ADA E16.5 epidermis (n = 22 divisions) compared to control (n = 70).
Each of the number of symmetric divisions (SCD), undefined divisions, or ACDs of the control was set to 100%. Significance was tested separately for each
division type (SCD, undefined and ACDs) using Student’s t test (n = 3 E16.5 embryos/genotype).
(D) Real-time qPCR analysis of control (set to 1) and E16.5 FoxO1-ADA epidermis showing altered expression of several p63 target genes compared to control,
which was set to 1 (mean of n = 4 embryos/genotype ± SEM). K15, Lce3B, and 14-3-3s are only weakly expressed at E16.5.
Statistical significance was tested using Student’s t test and indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S6.
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IGF/FoxO Control of p63 in Epidermal Developmentdetected by immunostaining. Thus far, only a few publications
show nuclear translocation of endogenous FoxOs by immuno-
histochemistry and only upon fasting and not loss of IIS (Kita-
mura et al., 2006).
Loss of p63 or epidermal expression of FoxO1-ADA phenotyp-
ically mimic each other and result in much more severe pheno-
type than combined epidermal loss of IR and IGF-1R. Although
this in part may be explained by the developmental timing of
deletion versus expression, this does suggest that other signals
than IIS control FoxO and p63 in epidermal morphogenesis.
Potential candidates are TGFb-superfamily members, as several
TGFb downstream transcription targets, some of which are also
regulated by p63, require the cooperative activity of Smad4 and
FoxOs in keratinocytes (Gomis et al., 2006). Perturbed FoxO-p63
interactions may also contribute to a range of common and rare184 Developmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier Inskin diseases characterized by disturbed epidermal differentia-
tion, such as psoriasis, ichthyosis, atopic dermatitis, and skin
cancer.
Our data provide evidence for a model in which IIS in keratino-
cytes controls epidermal morphogenesis through exclusion of
FoxO from the nucleus thereby releasing its inhibitory action on
p63. This in turn allows p63 to exert its transcriptional control
of genes that regulate proliferative potential, cell cycle progres-
sion, and spindle orientation. Our data suggest that 14-3-3s,
an important regulator of epidermal differentiation, might be
one of the key targets of IR/IGF-1R/FoxO/p63 axis. P63 pro-
moter binding inhibits Sfn transcription, which encodes 14-3-
3s (Westfall et al., 2003). This is relieved upon loss of insulin/
IGF-1 accompanied by increased FoxO binding to the p63 site
in the endogenous Sfn promoter resulting in more RNA andc.
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IGF/FoxO Control of p63 in Epidermal Developmentprotein expression. In line with our findings, overexpression of
14-3-3s in murine epidermis results in a hypomorphic phenotype
(Cianfarani et al., 2011), similar to the dkoepi mice. It was also
shown that 14-3-3s can induce G2/M arrest in cell culture (Rein-
hardt and Yaffe, 2009).
Although insulin/IGFs and FoxO have not yet been directly
implicated in the regulation of mitosis and ACD, AKT, the
upstream inhibitor of FoxO, regulates ACD in cancer cells (Dey-
Guha et al., 2011) and combined loss of Akt1 and Akt2 results
in less suprabasal layers similar to epidermal loss of IR and
IGF-1R (Peng et al., 2003). The small GTPase Rac, previously
shown to mediate IIS regulation on epidermal morphogenesis
likely upstream of Akt (Stachelscheid et al., 2008), has also
been implicated in control of ACD (Halet and Carroll, 2007; Lu
et al., 2012). How insulin/IGF-mediated regulation of FoxO and
p63 regulatesACDandmitotic progression to control thebalance
between proliferation and differentiation will be an important
question for the near future.
EXPERIMENTAL PROCEDURES
Mice
Epidermis-specific deletion of insulin receptor (IR), IGF-1-receptor (IGF-1R),
or both using K14-Cre-mediated deletion in mice have been described
(Stachelscheid et al., 2008). Conditional FoxO knockin mice carrying a
CACG promoter, a loxP-flanked stop cassette followed by the cDNA of consti-
tutively nuclear FoxO1-ADA or dominant negative FoxO1-DN in the Rosa26
locus (Belgardt et al., 2008; Sto¨hr et al., 2013) or a loxP-flanked stop cassette
followed by FoxO1-GFP in the Rosa26 locus (Fukuda et al., 2008) were
crossed to K14-Cre transgenic mice (Hafner et al., 2004) to induce
epidermal-specific expression. All mice are in C57Bl/6 background and exper-
iments were performed according to institutional guidelines and animal license
of the State Office North Rhine-Westphalia, Germany.
Immunohistochemistry and Immunofluorescence
For histology, embryos or mouse skin were fixed in 4% PFA and embedded in
paraffin. Paraffin sections (5 mm) were deparaffinized and stained with hema-
toxylin and eosin (H&E) and imaged with an Olympus BX51 microscope. For
immunofluorescence, paraffin sections were deparaffinized, antigens were
retrieved with buffer A, UG, or AG (EMS), and sections were blocked in PBS
containing 5% normal goat serum and 0.1% Triton X-100. Slides were incu-
bated with primary antibody followed by washing and incubation with the
appropriate secondary antibodies coupled to Alexa 488, Alexa 594, or Cy3
(Invitrogen). Nuclei were counterstained with DAPI (Sigma) and sections
examined using Olympus IX81 fluorescence or Olympus FV1000 confocal
microscopes. Primary antibodies are listed in Supplemental Experimental
Procedures.
Division Axis Orientation Determination
To analyze the angle of divisions, the axis of divisions in E16.5 embryos was
determined in anaphase/telophase cells using survivin staining as described
by Williams et al. (2011). The angle of division was determined by measuring
the angle of the plane transecting two daughter cells relative to the plane of
the basement membrane. The angles of divisions were quantified and angle
orientation was plotted with Oriana 4 (KCS). The different divisions were
then categorized as described with asymmetric divisions having an angle of
60–90, random 30–60, and symmetric 0–30 (Lechler and Fuchs, 2005).
Each of the total number of asymmetric, random, or symmetric divisions of
the control were then set to 100% to compared the relative loss within each
of the division categories to either knockouts or transgene.
Isolation and Transfection of Primary Keratinocytes and CHO Cells
Primary keratinocytes were isolated and cultured in minimal Ca2+ medium
(50 mM Ca2+) as described (Stachelscheid et al., 2008). For FoxO1 and
p63 overexpression, primary mouse keratinocytes were transfected usingDeveLipofectamine2000 (Invitrogen) at a confluence of 70%–90% according to
manufacturer’s protocol. CHO cells were transfected using Lipofectamine
(Invitrogen). For transfection 250 ng of the following plasmids were used:
pcDNA3-FoxO1-ADA, pcDNA3-FoxO1-ADA-DBD, and pCMV-FLAG-FoxO1
(Kitamura et al., 2007) and p63 plasmids pCMV-FAG-DNp63a (Ferone et al.,
2012), pEGFP-DNp63a, or pEGFP empty vector as control. For luciferase
reporter assays, cells were cotransfected with 25 ng pTK-Renilla (Promega)
and 250 ng of one of the following p63 luciferase reporters: 250 ng of pGL3-
BDS-2 (3x) and pG13-Luc (Hermeking et al., 1997; Yang et al., 1998) or the
6xDBE-Fkhre FoxO reporter (Potente et al., 2005). Experiments were per-
formed in triplicates and luciferase activity was determined 24 to 48 hr after
transfection with the dual-luciferase reporter assay kit (Promega) and a Bert-
hold TriStar Luminometer. Firefly luciferase activity was normalized for trans-
fection efficiency to Renilla luciferase activity. The results were presented as
the average of at least three independent experiments.
FACS Analysis
Cells were harvested by trypsin/EDTA treatment, washed in 5 ml PBS and
resuspended in 3 ml PBS. For fixation, cells were incubated with 70%
ethanol/PBS at 4C for minimum 2 hr and then centrifuged for 7 min at
1,000 rpm. The pellet was 23 washed with PBS, filtered with a 70 mm cell
strainer and resuspended in PBS containing 0.1% Triton X-100, RNase A
(10 mg/ml) and propidium iodide (2 mg/ml; Sigma). Cells were stained at
37C for 15 min and analyzed by FACS (FACScalibur, BD). FACS data were
analyzed using FlowJo software (Tree Star).
RNA Interference
To silence FoxO gene expression, keratinocytes were transfected with
ON-TARGET plus SMARTpool siRNAs (Thermo Fisher Scientific) targeting
FoxO1, FoxO3, FoxO4, and FoxO6. Subconfluent primary mouse keratino-
cytes were transfected using 50 nM of each SMARTpool or nontargeting
control pool and Lipofectamine2000 Reagent (Invitrogen) according to manu-
facturer’s protocol. Efficient knockdown was observed 48 hr posttransfection
in RT-PCR and western blot analysis.
Chromatin and Coimmunoprecipitation
For ChIP assays33 106 primary mouse keratinocytes or newborn epidermis
were crosslinked with 1% formaldehyde. Crosslinking was stopped and cells
lysed. Lysates were subjected to sonication on ice to obtain DNA fragments
ranging from 200 to 1,000 bp in length. The supernatant was diluted for immu-
noprecipitation in IP buffer (150 mM NaCl, 20 mM Tris pH 8, 2 mM EDTA) and
precleared with protein A beads (Roche). Supernatant was incubated with 4 mg
antibody overnight at 4C, and beads were sequentially washed as previously
described (Ferone et al., 2012). Chromatin was eluted, DNA was purified and
analyzed by quantitative real-time PCR, or protein was analyzed by western
blot. Real-time PCR was performed using the SYBR Green PCR master mix
(Applied Biosystems) in an ABI StepOne light cycler. Primer sets for analysis
are listed in Supplemental Experimental Procedures.
For Co-IP, CHO cells were lysed in HEPES buffer (50 mM HEPES-KOH pH
7.8; 140mMNaCl; 1mMEDTA; 10% glycerol; 0.25% Triton X-100; 1%NP-40)
for 20 min at 4C, subsequently nuclei were disrupted by mild sonication and
lysate after preclearing incubated with 4 mg of antibody overnight. Antibodies
were precipitated with Protein A/G (Roche) beads and after washing in IP
buffer, samples were analyzed by western blot.
Quantitative Real-Time PCR and Global Gene Expression Analysis
Gene expression was analyzed using quantitative real-time PCR. RNA was
extracted from keratinocytes and epidermis using Trizol (Invitrogen) and
RNeasy Minikit (QIAGEN). RNA was reversely transcribed with Quantitect
Reverse Transcriptase (QIAGEN) and amplified using the TaqMan Universal
PCR Master Mix (Applied Biosystems). PCR was performed on an ABI
StepONE Plus machine. Calculations were performed by comparative cycle
threshold (DDCt) method with data normalized relative to 18S and Hprt1.
Probes for target genes were ordered from TaqMan Assay-on-Demand Kits
(AppliedBiosystems). TaqMan probes are listed in Supplemental Experimental
Procedures. For microarray analysis, RNA was isolated from control and
dkoepi/ epidermis (n = 4 each) and sent to the DNA Sciences Core at the
University of Virginia for labeling, amplification, and hybridization to thelopmental Cell 26, 176–187, July 29, 2013 ª2013 Elsevier Inc. 185
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IGF/FoxO Control of p63 in Epidermal DevelopmentAffymetrix 430-2.0 platform. For global gene expression analysis, significantly
regulated genes sets (p < 0.05) from the different microarrays were analyzed
for overlap using VENNY Tool by Oliveros (http://bioinfogp.cnb.csic.es/tools/
venny/index.html). The significance of overlapping and nonoverlapping genes
was determined using hypergeometric distribution algorithm. Overlapping and
nonoverlapping gene sets were then annotated using DAVID functional anno-
tation tool (Dennis et al., 2003).
Protein Isolation and Immunoblotting
Epidermis was separated from dermis and dissociated with a MixerMill
homogenizer and lysed in 1% SDS lysis buffer. Primary keratinocytes were
scraped of culture dishes and lysed in 1%SDS lysis buffer. Lysates were sepa-
rated on SDS-PAGE gels (Novex), transferred to a PVDF membrane, blocked
in 5% western blot blocking solution (Roche) and incubated with primary
antibodies followed by incubation with the appropriate horseradish peroxidase
coupled secondary antibodies and detected using ECL (Thermo Fisher
Scientific).
Statistical Methods
Data were analyzed for statistical significance using two-tailed unpaired
Student’s t test unless otherwise stated. Relative loss of ACD, random
divisions, and SCD were tested using one-way ANOVA in Prism 5 (GraphPad).
The asterisks shown in graphs correspond to the p values as stated in the
figure legends. The results were presented as the average of at least three
independent experiments unless otherwise stated in the legends and arrow
bars indicate SD or SEM.
ACCESSION NUMBERS
Microarray data have been deposited into the GEO database with accession
number GSE47065.
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